A global pharmaceutical company used the pandemic as a springboard to reshape travel behaviours, reducing unnecessary trips while empowering employees with choice.
Find out how we used our expertise in Communications, Change and Listening to help spark this cultural shift and achieve standout results…
The company saw the pandemic travel restrictions as an opportunity to make lasting change. Internal travel – mainly for meetings – accounted for 70% of spend. The challenge was to:
We combined behavioural science with creative employee engagement to reframe travel decisions.
The campaign reached 13 countries in 2022 and within the first year achieved a 52% reduction in travel spend compared with 2019 – equating to £130 million saved.
Beyond financial impact, it also created a reduction of 12 million tonnes of CO2, contributing significantly to sustainability goals.
This campaign helped employees embrace new norms around travel, fostering a more sustainable, empowered, and thoughtful culture around when and how to meet.
This project was recognised by the Institute of Internal Communication (IoIC) for Best Change/Transformation.
Jump to a slide with the slide dots.
CASE STUDY (US) Neuro Discovery Lead Team Drives Results for Rare Disease
Read moreCASE STUDY (US) Building a 400+ Rep Seasonal Sales Team with Agility
Read moreSee how we helped Nissan transformed its Chairman’s Innovation Awards with inclusivity, creativity and innovation - boosting entries 900% and...
Read more